Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study.

Antibiotics (Basel) · 2022 · PMC8868075 · PMID 35203844

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The confidence interval was set to 95% and the p -value ( p < 0.05) was considered significant (S) and p < 0.01: Highly significant (HS). 5.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.